We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+16.45%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$37B
AUM Growth
+$4.8B
Cap. Flow
+$1.03B
Cap. Flow %
2.78%
Top 10 Hldgs %
36.45%
Holding
1,839
New
21
Increased
351
Reduced
1,246
Closed
128

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$380M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$341M
3
NVDA icon
NVIDIA
NVDA
+$253M
4
AMZN icon
Amazon
AMZN
+$245M
5
JPM icon
JPMorgan Chase
JPM
+$236M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$192M
2
DFS
Discover Financial Services
DFS
+$153M
3
CMCSA icon
Comcast
CMCSA
+$140M
4
KO icon
Coca-Cola
KO
+$117M
5
GDDY icon
GoDaddy
GDDY
+$103M

Sector Composition

Rank Sector Weight
1 Technology 35.4%
2 Financials 14.08%
3 Communication Services 12.92%
4 Healthcare 12.04%
5 Consumer Discretionary 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNLI icon
1476
Denali Therapeutics
DNLI
$3.9B
$63K ﹤0.01%
4,495
-1,955
-30% -$27.5K
HUT
1477
Hut 8
HUT
$11.2B
$63K ﹤0.01%
3,379
MBC icon
1478
MasterBrand
MBC
$1.13B
$63K ﹤0.01%
5,800
NSP icon
1479
Insperity
NSP
$1.9B
$63K ﹤0.01%
1,045
-483
-32% -$33.8K
PHIN icon
1480
Phinia Inc
PHIN
$2.77B
$63K ﹤0.01%
1,422
-758
-35% -$32K
ATEN icon
1481
A10 Networks
ATEN
$2.07B
$62K ﹤0.01%
3,197
-2,057
-39% -$35.1K
BCRX icon
1482
BioCryst Pharmaceuticals
BCRX
$2.4B
$62K ﹤0.01%
6,947
-3,251
-32% -$30.3K
BTU icon
1483
Peabody Energy
BTU
$2.85B
$62K ﹤0.01%
4,609
-2,442
-35% -$32.2K
LBRT icon
1484
Liberty Energy
LBRT
$3.23B
$62K ﹤0.01%
5,432
-2,679
-33% -$32.4K
PBF icon
1485
PBF Energy
PBF
$7.14B
$62K ﹤0.01%
2,844
-1,330
-32% -$25.3K
RXRX icon
1486
Recursion Pharmaceuticals
RXRX
$1.66B
$62K ﹤0.01%
12,307
TCBK icon
1487
TriCo Bancshares
TCBK
$1.86B
$62K ﹤0.01%
1,532
TVTX icon
1488
Travere Therapeutics
TVTX
$6.06B
$62K ﹤0.01%
4,187
UPBD icon
1489
Upbound Group
UPBD
$1.16B
$62K ﹤0.01%
2,454
VBTX
1490
DELISTED
Veritex Holdings
VBTX
$62K ﹤0.01%
2,387
-1,577
-40% -$37.6K
ACHC icon
1491
Acadia Healthcare
ACHC
$2.95B
$61K ﹤0.01%
2,686
-1,349
-33% -$32K
ASND icon
1492
Ascendis Pharma A/S
ASND
$16.6B
$61K ﹤0.01%
356
-55
-13% -$8.96K
AVPT icon
1493
AvePoint
AVPT
$2.8B
$61K ﹤0.01%
3,154
-1,501
-32% -$26K
BLBD icon
1494
Blue Bird Corp
BLBD
$2.26B
$61K ﹤0.01%
1,420
CERT icon
1495
Certara
CERT
$1.23B
$61K ﹤0.01%
5,237
FBK icon
1496
FB Financial Corp
FBK
$3.07B
$61K ﹤0.01%
1,339
-751
-36% -$32.6K
FCF icon
1497
First Commonwealth Financial
FCF
$2.19B
$61K ﹤0.01%
3,772
-2,070
-35% -$31.9K
HUBG icon
1498
HUB Group
HUBG
$2.83B
$61K ﹤0.01%
1,830
-1,851
-50% -$62.1K
LKFN icon
1499
Lakeland Financial Corp
LKFN
$1.57B
$61K ﹤0.01%
998
-599
-38% -$34.8K
LMAT icon
1500
LeMaitre Vascular
LMAT
$1.86B
$61K ﹤0.01%
738
-374
-34% -$31.3K

Similar funds

KBC Group's Q2 2025 Portfolio in Review

As of Q2 2025, KBC Group held 1,839 positions worth $37B, up 15% from $32.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

KBC Group's Q2 2025 filing shows 21 new, 351 increased, 1,246 reduced and 128 closed positions. Its largest new stake was Ralliant Corp: 87,075 shares worth $4.22M. The largest sale was IBM, an estimated $192M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Communication Services.

  • KBC Group's largest Q2 2025 buy was Ralliant Corp: 87,075 shares worth $4.22M.
  • KBC Group added most to Microsoft in Q2 2025, an estimated $380M increase.
  • KBC Group's biggest Q2 2025 reduction was IBM, cutting an estimated $192M.
  • KBC Group fully exited Discover Financial Services in Q2 2025, selling an estimated $153M.
  • KBC Group's ten largest holdings make up 36% of its $37B portfolio in Q2 2025.
  • KBC Group opened 21 new positions and closed 128 in Q2 2025.
  • KBC Group's portfolio value rose 15% quarter-over-quarter to $37B.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.